Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Nonalcoholic Steatohepatitis in Chinese Children

Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality. A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.

Who May Be Eligible (Plain English)

Who May Qualify: - age 1-18 with biopsy-proven NAFLD - Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively Who Should NOT Join This Trial: - with viral hepatitis, e.g. HBV, HCV - with a1-anti-trypsin disease - with autoimmune hepatitis - with Wilson disease - with liver impaired by drugs Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * age 1-18 with biopsy-proven NAFLD * Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively Exclusion Criteria: * with viral hepatitis, e.g. HBV, HCV * with a1-anti-trypsin disease * with autoimmune hepatitis * with Wilson disease * with liver impaired by drugs

Treatments Being Tested

OTHER

No intervention

There will be no specific intervention to these paediatric NASH patient

Locations (1)

Children's Liver Disease Center, 302 Hospital
Beijing, China